{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1521980705254530816.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"NDL_BIB_ID","@value":"10961800"}},{"identifier":{"@type":"URI","@value":"http://id.ndl.go.jp/bib/10961800"}},{"identifier":{"@type":"URI","@value":"https://ndlsearch.ndl.go.jp/books/R000000004-I10961800"}},{"identifier":{"@type":"DOI","@value":"10.1007/s10384-010-0886-x"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/content/pdf/10.1007/s10384-010-0886-x.pdf"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/article/10.1007/s10384-010-0886-x/fulltext.html"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/content/pdf/10.1007/s10384-010-0886-x"}},{"identifier":{"@type":"PMID","@value":"21331691"}},{"identifier":{"@type":"NAID","@value":"10029020551"}},{"identifier":{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/2012046015"}}],"dc:title":[{"@value":"Clinical investigation: Three-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy"},{"@language":"ja-Kana","@value":"Clinical investigation Three year follow up results of photodynamic therapy for polypoidal choroidal vasculopathy"}],"dcterms:alternative":[{"@value":"Clinical investigation: Three-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy"}],"dc:language":"en","description":[{"notation":[{"@value":"To evaluate the visual outcomes and changes in abnormal vascular networks and polypoidal lesions of polypoidal choroidal vasculopathy (PCV) 3 years after photodynamic therapy (PDT).We studied 43 eyes of 43 patients with PCV for 3 years. Fundus appearance, fluorescein angiography (FA) and indocyanine green angiography (IA) findings, and visual acuity (VA) before the initial PDT were compared with those 3 months, 1 year, 2 years, and 3 years after treatment.In 24 of the 43 eyes, enlargement of the abnormal vascular network continued in a manner similar to that before PDT on IA; in eight eyes, transformation into polypoidal choroidal neovascularization (CNV) with enlargement was detected; and two eyes had the appearance of classic CNV on FA. Polypoidal lesions recurred at 3 years in 33 of the 43 eyes (77%). Mean VA (logarithm of the minimum angle of resolution) of all 43 eyes decreased to below baseline at 3 years after the initial PDT. This decrease can be explained by foveal atrophy after absorption of recurrent hemorrhagic or exudative detachment.Long-term visual outcomes were not good owing to the high frequency of recurrent polypoidal lesions, as well as enlargement and neovascular changes involving abnormal vascular networks."}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1580009750578036228","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000002010342"}],"foaf:name":[{"@value":"Eriko Akaza"}]},{"@id":"https://cir.nii.ac.jp/crid/1580009750578036225","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000001257451"}],"foaf:name":[{"@value":"Ryusaburo Mori"}]},{"@id":"https://cir.nii.ac.jp/crid/1420001326222334464","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"60139160"},{"@type":"NRID","@value":"1000060139160"},{"@type":"NRID","@value":"9000001257448"},{"@type":"NRID","@value":"9000279645515"},{"@type":"NRID","@value":"9000001394115"},{"@type":"NRID","@value":"9000001336681"},{"@type":"NRID","@value":"9000015412324"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/read0028671"}],"foaf:name":[{"@value":"Mitsuko Yuzawa"}]}],"publication":{"publicationIdentifier":[{"@type":"NDL_BIB_ID","@value":"000000120860"},{"@type":"ISSN","@value":"00215155"},{"@type":"PISSN","@value":"00215155"},{"@type":"EISSN","@value":"16132246"},{"@type":"NCID","@value":"AA00691177"}],"prism:publicationName":[{"@value":"Japanese journal of ophthalmology : the official international journal of the Japanese Ophthalmological Society / Japanese Ophthalmological Society"}],"dc:publisher":[{"@value":"[Tokyo] : [Springer Japan]"}],"prism:publicationDate":"2011","prism:volume":"55","prism:number":"1","prism:startingPage":"39","prism:endingPage":"44"},"reviewed":"false","url":[{"@id":"http://id.ndl.go.jp/bib/10961800"},{"@id":"https://ndlsearch.ndl.go.jp/books/R000000004-I10961800"},{"@id":"http://link.springer.com/content/pdf/10.1007/s10384-010-0886-x.pdf"},{"@id":"http://link.springer.com/article/10.1007/s10384-010-0886-x/fulltext.html"},{"@id":"http://link.springer.com/content/pdf/10.1007/s10384-010-0886-x"},{"@id":"https://search.jamas.or.jp/link/ui/2012046015"}],"foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=indocyanine%20green%20angiography","dc:title":"indocyanine green angiography"},{"@id":"https://cir.nii.ac.jp/all?q=photodynamic%20therapy","dc:title":"photodynamic therapy"},{"@id":"https://cir.nii.ac.jp/all?q=polypoidal%20choroidal%20vasculopathy","dc:title":"polypoidal choroidal vasculopathy"},{"@id":"https://cir.nii.ac.jp/all?q=visual%20acuity","dc:title":"visual acuity"}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050282810738481792","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Visual prognosis of eyes with submacular hemorrhage associated with exudative age-related macular degeneration."},{"@value":"CLINICAL INVESTIGATION : Visual prognosis of eyes with submacular hemorrhage associated with exudative age-related macular degeneration"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292619638280064","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292621573507072","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"INDOCYANINE GREEN VIDEOANGIOGRAPHY OF IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565168459123968","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Three-year visual outcome of photodynamic therapy plus intravitreal bevacizumab with or without subtenon triamcinolone acetonide injections for polypoidal choroidal vasculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574094799652608","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Polypoidal choroidal vasculopathy: natural history"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095518122752","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Long-term follow-up of polypoidal choroidal vasculopathy after photodynamic therapy with verteporfin"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855571148391168","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Indocyanine Green Angiography: Guided Photodynamic Therapy for Polypoidal Choroidal Vasculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137043463186816","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Polypoidal Choroidal Vasculopathy and Neovascularized Age-related Macular Degeneration"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137044405562496","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Long-Term Results of Photodynamic Therapy of Polypoidal Choroidal Vasculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1361697223510022912","@type":"Article","relationType":["references","cites"],"jpcoar:relatedTitle":[{"@value":"Correlation Between Indocyanine Green Angiographic Findings and Histopathology of Polypoidal Choroidal Vasculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981468421735552","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Role of Photodynamic Therapy in Polypoidal Choroidal Vasculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981470791217920","@type":"Article","relationType":["references","cites"],"jpcoar:relatedTitle":[{"@value":"Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981471256559616","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"One-Year Outcomes of Photodynamic Therapy in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in Japanese Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262943686662400","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"SELECTIVE PHOTODYNAMIC THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH POLYPOIDAL CHOROIDAL NEOVASCULARIZATION"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262945752304000","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY (IPCV)"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544419615348096","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"INTRAVITREAL BEVACIZUMAB TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544419857829376","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The origins of polypoidal choroidal vasculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544420182443776","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Photodynamic Therapy with Verteporfin in the Treatment of Exudative Idiopathic Polypoidal Choroidal Vasculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544421317077632","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY WITH PHOTODYNAMIC THERAPY"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825894746879744","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Photodynamic Therapy with Verteporfin for Polypoidal Choroidal Vasculopathy of the Macula"}]},{"@id":"https://cir.nii.ac.jp/crid/1363104598394285312","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Two-year results of combined intravitreal anti-VEGF agents and photodynamic therapy for retinal angiomatous proliferation"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107370661078528","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107370855587584","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The Therapeutic Effects of Bevacizumab in Patients with Polypoidal Choroidal Vasculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670318824257152","@type":"Article","relationType":["references","cites"],"jpcoar:relatedTitle":[{"@value":"Polypoidal Choroidal Vasculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951793535998080","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clinicopathologic Findings in Polypoidal Choroidal Vasculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951794640013440","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Marked vascular changes of polypoidal choroidal vasculopathy after photodynamic therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951795230488832","@type":"Article","relationType":["references","cites"],"jpcoar:relatedTitle":[{"@value":"Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin"}]},{"@id":"https://cir.nii.ac.jp/crid/1520009408420381184","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"典型加齢黄斑変性・ポリープ状脈絡膜血管症に対して初回治療として光線力学療法を行った患者と導入前患者の5年間の臨床経過比較"},{"@language":"ja-Kana","@value":"テンケイカレイオウ ハン ヘンセイ ・ ポリープジョウ ミャクラクマク ケッカンショウ ニ タイシテ ショカイ チリョウ ト シテ コウセン リキガク リョウホウ オ オコナッタ カンジャ ト ドウニュウ ゼン カンジャ ノ 5ネンカン ノ リンショウ ケイカ ヒカク"}]},{"@id":"https://cir.nii.ac.jp/crid/1520291855080507136","@type":"Article","relationType":["references","cites"],"jpcoar:relatedTitle":[{"@value":"Clinical investigations: Photodynamic therapy for age-related macular degeneration in Japanese patients: results after one year"},{"@language":"ja-Kana","@value":"Clinical investigations Photodynamic therapy for age related macular degeneration in Japanese patients results after one year"}]},{"@id":"https://cir.nii.ac.jp/crid/1520572356975893376","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"臨床研究 加齢黄斑変性に対する光線力学的療法による病勢沈静化後に再発した症例の背景因子"},{"@language":"ja-Kana","@value":"リンショウ ケンキュウ カレイオウ ハン ヘンセイ ニ タイスル コウセン リキガクテキ リョウホウ ニ ヨル ビョウセイ チンセイカ ゴ ニ サイハツ シタ ショウレイ ノ ハイケイ インシ"}]},{"@id":"https://cir.nii.ac.jp/crid/1520573331018789760","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@value":"CLINICAL INVESTIGATION : Choroidal thickness outside the laser irradiation area after photodynamic therapy in polypoidal choroidal vasculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1520853833592859520","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"第115回 日本眼科学会総会 特別講演 ポリープ状脈絡膜血管症"},{"@language":"ja-Kana","@value":"ダイ115カイ ニホン ガンカ ガッカイ ソウカイ トクベツ コウエン ポリープジョウ ミャクラクマク ケッカンショウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1521136280486107520","@type":"Article","relationType":["references","cites"],"jpcoar:relatedTitle":[{"@value":"Clinical investigation: Effects of photodynamic therapy on the choriocapillaris and retinal pigment epithelium in the irradiated area"},{"@language":"ja-Kana","@value":"Clinical investigation Effects of photodynamic therapy on the choriocapillaris and retinal pigment epithelium in the irradiated area"}]},{"@id":"https://cir.nii.ac.jp/crid/1521699230361010688","@type":"Article","relationType":["references","cites"],"jpcoar:relatedTitle":[{"@value":"Clinical investigations: Role of photodynamic therapy in polypoidal choroidal vasculopathy"},{"@language":"ja-Kana","@value":"Clinical investigations Role of photodynamic therapy in polypoidal choroidal vasculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1522262180529026688","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"光線力学的療法を施行したラニビズマブ反応不良ポリープ状脈絡膜血管症7例"},{"@language":"ja-Kana","@value":"コウセン リキガクテキ リョウホウ オ シコウ シタ ラニビズマブ ハンノウ フリョウ ポリープジョウ ミャクラクマク ケッカンショウ 7レイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1523106604848736256","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@value":"CLINICAL INVESTIGATION : Two-year results of reduced-fluence photodynamic therapy combined with intravitreal ranibizumab for typical age-related macular degeneration and polypoidal choroidal vasculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1523669555364359168","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@value":"CLINICAL INVESTIGATION : Treatment results at 1 year of ranibizumab therapy for polypoidal choroidal vasculopathy in eyes with good visual acuity"}]},{"@id":"https://cir.nii.ac.jp/crid/1524232505725574272","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@value":"CLINICAL INVESTIGATION : Comparison of different treatment intervals between bevacizumab injection and photodynamic therapy in combined therapy for age-related macular degeneration"}]},{"@id":"https://cir.nii.ac.jp/crid/1570009750089795328","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1570572700043217536","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Idiopathic polypoidal choroidal vasculopathy (IPCV)"}]},{"@id":"https://cir.nii.ac.jp/crid/1570572700043218688","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Treatment of polypoidal choroidal vasculopathy with polypoidal choroidal vasculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1570572700043220992","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration"}]},{"@id":"https://cir.nii.ac.jp/crid/1570572700043224704","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization"}]},{"@id":"https://cir.nii.ac.jp/crid/1570854175019933696","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1571417124973351168","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1571417124973353216","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A Study of findings from indocyanine fundus angiography with HRA in polypoidal choroidal vasculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1571417124973356416","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Photodynamic therapy with verteporfin in the treatment of exudative idiopathic polypoidal choroidal vasculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1571698599950059392","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration"}]},{"@id":"https://cir.nii.ac.jp/crid/1571698599950060416","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Indocyanine green angiography guided photodynamic therapy for polypoidal choroidal vasculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1571698599950067712","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Clinicopathologic findings in polypoidal choroidal vasculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1571980074926774528","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Polypoidal choroidal vasculopathy pattern in age-related macular degeneration : a clinicopathologic correlation"}]},{"@id":"https://cir.nii.ac.jp/crid/1572824499856904192","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The origins of polypoidal choroidal vasculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1572824499856910208","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Long-term follow-up of polypoidal choroidal vasculopathy after photodynamic therapy with verteporfin"}]},{"@id":"https://cir.nii.ac.jp/crid/1573105974833613696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Marked vascular changes of polypoidal choroidal vasculopathy after photodynamic therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1573105974833614976","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Pathology of polypoidal choroidal vasculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1573105974833616000","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Role of photodynamic therapy in polypoidal choroidal vasculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1573387449810331648","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the macula"}]},{"@id":"https://cir.nii.ac.jp/crid/1573387451146340608","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Clinical characteristics of exudative age-related macular degeneration in Japanese patients"},{"@value":"Clinical characteristics of exudative age‐related macular degeneration in Japanese patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1573668924787033088","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1573668924787039488","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Polypoidal choroidal vasculopathy treated with macular translocation"}]},{"@id":"https://cir.nii.ac.jp/crid/1573668924787041920","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Polypoidal choroidal vasculopathy. Natural history"}]},{"@id":"https://cir.nii.ac.jp/crid/1574231874740462592","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Clinical characteristics of exudative age-related macular degeneration in Japanese patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1574231874740463744","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Photodynamic therapy with verteporfin for symptomatic polypoidal vasculopathy : one-year results of a prospective case series"}]}],"dataSourceIdentifier":[{"@type":"NDL_SEARCH","@value":"oai:ndlsearch.ndl.go.jp:R000000004-I10961800"},{"@type":"CROSSREF","@value":"10.1007/s10384-010-0886-x"},{"@type":"CIA","@value":"10029020551"},{"@type":"OPENAIRE","@value":"doi_dedup___::7485a1ed76caadd930dd6887b979cd30"},{"@type":"CROSSREF","@value":"10.1007/s10384-012-0191-y_references_DOI_DV9vGCT7ZPDISbLNJnbLJMVNm6V"},{"@type":"CROSSREF","@value":"10.1007/s10384-013-0230-3_references_DOI_DV9vGCT7ZPDISbLNJnbLJMVNm6V"},{"@type":"CROSSREF","@value":"10.1007/s10384-013-0234-z_references_DOI_DV9vGCT7ZPDISbLNJnbLJMVNm6V"},{"@type":"CROSSREF","@value":"10.1136/bjophthalmol-2014-305189_references_DOI_DV9vGCT7ZPDISbLNJnbLJMVNm6V"},{"@type":"CROSSREF","@value":"10.1007/s10384-012-0154-3_references_DOI_DV9vGCT7ZPDISbLNJnbLJMVNm6V"},{"@type":"CROSSREF","@value":"10.1007/s10384-013-0245-9_references_DOI_DV9vGCT7ZPDISbLNJnbLJMVNm6V"},{"@type":"CROSSREF","@value":"10.1007/s10384-012-0215-7_references_DOI_DV9vGCT7ZPDISbLNJnbLJMVNm6V"}]}